Here’s what you should know:
1. The proceeds of the offering will redeem the 2.65 percent notes that were due October 2016. Boston Scientific had approximately $600 million in aggregate principal outstanding on the notes as of Feb. 26.
2. The company needs to repay short-term debt and related fees, expenses and premiums.
3. Once paid, Boston Scientific will provide redemption notices to trustees.
More articles on supply chain:
CMS made $36B in improper payments in FY2017 — 6 key notes
18 statistics on changes in ASC payer rates, supply costs, staff raises & expenses
Indianapolis pain practice looks to expand Midwest presence with private equity investment
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.